Consumption of Potatoes, Avocados and Chickpeas and Cognitive Function in Older Adults
NCT ID: NCT01620567
Last Updated: 2019-07-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2012-08-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The proposed study is designed as a randomized, placebo controlled trial that tests the effects of 6 month supplementation with 1 avocado/day on cognitive function in older adults. Secondary analyses will determine whether baseline macular pigment (lutein in retina which canbe measured non invasivley) density predicts relative effectiveness of the intervention on cognitive function. Secondary outcomes include plasma biomarkers of oxidative stress and inflammation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adults
NCT06137339
The Effect of Consumption of Almonds and Snack Mix Daily for 6 Months on Cognitive Function in Older Adults
NCT03093896
Nutraceutical Effects on Long-Term Memory
NCT01963767
The Effects of Strawberry Supplementation on Memory and Gait Among Over-weight Older Adults
NCT03162913
Effect of Daily Mixed Spice Consumption on Memory Function
NCT06889961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
chickpeas/potatoes
1 potato/day or 1 cup chickpeas
potato or chickpea
1 cup potatoes or chickpeas/day for 6 months
avocados
1 avocados/day
avocado
1 avocado/day for 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
avocado
1 avocado/day for 6 months
potato or chickpea
1 cup potatoes or chickpeas/day for 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 19-30 kg/m2
* lutein intake of \< 3 mg/d
* Docosahexaenoic acid intake \< 250 mg/d (including supplements)
* Mini mental state exam (MMSE) score \> 24
* Macular pigment density \< 0.4 at 0.5 degrees
* Beck Depression Inventory \< 20
* free of known disease
* BMI 19-29 kg/m2
* must be able to give written informed consent
* have normal hematologic parameters
* normal values of plasma albumin
* normal values for liver and kidney function (Appendix A)
* no use of carotenoid, n3 fatty acid, multivitamin/mineral, (\> 2 months).
Exclusion Criteria
* atrophic gastritis
* hyperlipidemia (LDL \>120 mg/dL or triglycerides \>150 mg/dL)
* hypertension (\>150/90 mm Hg)
* diabetes, alcoholism (\>2 drinks/d or 14 drinks/week)
* pancreatic disease
* anemia, and bleeding disorders (as determined by screening interview)
* avocado, potato or chickpea allergy
* pregnancy or lactation
* diseases that interfere with fat absorption, e.g. colitis, celiac disease, Crohn's disease, cystic fibroids (as determined by screening interview)
* medications that interfere with fat absorption, e.g. bile sequestrants (as determined by screening interview)
* use of antipsychotic, antimanic, anti-inflammatory, monoamine inhibitors, or dementia medications
* smoking or use of nicotine patches or gum (within past 6 months)
* use of drugs suspected of interfering with metabolism of blood clotting, e.g. warfarin (as determined by screening interview)
* subjects having extremely high dietary intakes of carotenoids as indicated by screening plasma values \> NHANES 95th percentile for lutein/zeaxanthin, beta-carotene, cryptoxanthin, or lycopene
* stroke,head injury with loss of consciousness or seizures.
* Non English speaking: This is a small study with a sample size. Logistically and financially, getting materials translated for such a small study is not feasible.
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tufts University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth J Johnson, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Tufts University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.